- Home
- FFIN vs AXSM Comparison
FFIN vs AXSM Comparison
Compare FFIN & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFIN
- AXSM
- Stock Information
- Founded
- FFIN 1890
- AXSM 2012
- Country
- FFIN United States
- AXSM United States
- Employees
- FFIN N/A
- AXSM N/A
- Industry
- FFIN Major Banks
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- FFIN Finance
- AXSM Health Care
- Exchange
- FFIN Nasdaq
- AXSM Nasdaq
- Market Cap
- FFIN 5.3B
- AXSM 6.3B
- IPO Year
- FFIN N/A
- AXSM 2015
- Fundamental
- Price
- FFIN $35.69
- AXSM $111.67
- Analyst Decision
- FFIN Hold
- AXSM Strong Buy
- Analyst Count
- FFIN 4
- AXSM 14
- Target Price
- FFIN $40.25
- AXSM $168.93
- AVG Volume (30 Days)
- FFIN 572.2K
- AXSM 593.1K
- Earning Date
- FFIN 04-17-2025
- AXSM 05-05-2025
- Dividend Yield
- FFIN 2.03%
- AXSM N/A
- EPS Growth
- FFIN 12.23
- AXSM N/A
- EPS
- FFIN 1.56
- AXSM N/A
- Revenue
- FFIN $536,909,000.00
- AXSM $385,693,000.00
- Revenue This Year
- FFIN $17.00
- AXSM $64.53
- Revenue Next Year
- FFIN $4.62
- AXSM $63.26
- P/E Ratio
- FFIN $23.03
- AXSM N/A
- Revenue Growth
- FFIN 11.58
- AXSM 42.53
- 52 Week Low
- FFIN $27.62
- AXSM $64.11
- 52 Week High
- FFIN $44.66
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- FFIN 43.26
- AXSM 36.05
- Support Level
- FFIN $34.57
- AXSM $117.60
- Resistance Level
- FFIN $37.14
- AXSM $122.97
- Average True Range (ATR)
- FFIN 0.79
- AXSM 4.47
- MACD
- FFIN 0.05
- AXSM -1.66
- Stochastic Oscillator
- FFIN 43.58
- AXSM 20.13
About FFIN First Financial Bankshares Inc.
First Financial Bankshares Inc is a financial and bank holding company. The company operates one line of business (community banking) located in a single geographic area (Texas). The company conducts a full-service commercial banking business through its subsidiaries. The loan portfolio segments of the company include Commercial and Industrial, Municipal, Agricultural, Construction and Development, Farm, Non-Owner Occupied and Owner Occupied Commercial Real Estate, Residential, Consumer Auto and Consumer Non-Auto. It derives maximum revenue from Construction and Development Segment.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.